Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPRB | P23467 | 5/20 | 0.52 |
| ▸ | UTS2R | Q9UKP6 | 3/20 | 0.46 |
| ▸ | CNR2 | P34972 | 11/20 | 0.45 |
| ▸ | CNR1 | P21554 | 1/20 | 0.45 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.44 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.44 |
| ▸ | PTPRA | P18433 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6804564 | 0.80 | ALDH1A1 (0.49) | ALDH1A1 | |
| SCHEMBL6803112 | 0.78 | CTSL (0.56) | PTPRB | |
| SCHEMBL6916260 | 0.75 | CNR2 (0.45) | UTS2RCNR2CNR1KDM4EALDH1A1 | |
| SCHEMBL3923649 | 0.75 | PTPRB (0.73) | PTPRB | |
| SCHEMBL27558113 | 0.72 | CNR2 (0.65) | UTS2RCNR2CNR1ALDH1A1 | |
| SCHEMBL6956276 | 0.72 | CNR2 (0.65) | UTS2RCNR2CNR1ALDH1A1 | |
| SCHEMBL28760324 | 0.72 | CNR2 (0.65) | UTS2RCNR2CNR1ALDH1A1 | |
| SCHEMBL22646979 | 0.70 | PTPRB (0.68) | PTPRB | |
| SCHEMBL19002839 | 0.70 | KMT2A (0.62) | ALDH1A1 | |
| SCHEMBL6953151 | 0.70 | KMT2A (0.71) | UTS2RCNR2CNR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2004074238-A1 | PHENETHYLAMINO SULFAMIC ACIDS | THE PROCTER & GAMBLE COMPANY (US) | 2004-09-02 | — | — | WO | claimed |
| US-20040167183-A1 | Phenethylamino sulfamic acids | THE PROCTER & GAMBLE COMPANY | 2004-08-26 | — | — | US | claimed |
| WO-2004074238-A1 | PHENETHYLAMINO SULFAMIC ACIDS | THE PROCTER & GAMBLE COMPANY (US) | 2004-09-02 | — | — | WO | disclosed |
| US-20040167183-A1 | Phenethylamino sulfamic acids | THE PROCTER & GAMBLE COMPANY | 2004-08-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040167183-A1 | Phenethylamino sulfamic acids | PTPRM, PTPRS, PTPRE | PTPRB 13/4885UTS2R 2643/4885CNR2 4684/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.